Total of 192 potential targets were obtained from 108 active ingredients after removing the redundancy (Supplementary Table 2), including MDM2, TNFBR1, MAPK14, and SRC, involved in inflammation, hepatic lipid metabolism, and the development of hepatic fibrosis. The gene discussed is MAPK14; the disease is Hepatic fibrosis.